Position history for FRONTIER CAPITAL MANAGEMENT CO LLC's holdings in BRIDGEBIO PHARMA INC
FRONTIER CAPITAL MANAGEMENT CO LLC holds 957,989 shares of BBIO (BRIDGEBIO PHARMA INC), worth $71.1M as of 2026-Q1. The position was increased (+16.0% shares). BBIO represents 0.7% of FRONTIER CAPITAL MANAGEMENT CO LLC's portfolio.
Current Value
$71.1M
Current Shares
957,989
Total Value Change
+$67.4M
Total Shares Change
+809,621
Other major holders of BBIO: UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Increased |
| 957,989 |
+16.0% |
| $71.1M |
| 0.7% |
| $64.53 |
48 |
| 2025-Q4 | Increased | 826,131 | +25.2% | $63.2M | 0.7% | $75.48 | 51 |
| 2025-Q3 | Increased | 659,633 | +23.1% | $34.3M | 0.3% | $51.96 | 42 |
| 2025-Q2 | Decreased | 535,763 | -30.4% | $23.1M | 0.2% | $44.86 | 0 |
| 2025-Q1 | Decreased | 769,301 | -28.5% | $26.6M | 0.3% | $35.11 | 0 |
| 2024-Q4 | Increased | 1.1M | +113.8% | $29.5M | 0.3% | $27.32 | 56 |
| 2024-Q3 | Increased | 503,162 | +239.1% | $12.8M | 0.1% | $24.94 | 54 |
| 2024-Q2 | Decreased | 148,368 | -67.0% | $3.8M | 0.0% | $25.33 | 0 |